VRTX

VRTX Deferred Revenue

$0.00Quarterly · USD

Period ending:

VRTX FY Deferred RevenueUSD
VRTX FY Deferred Revenue1990-12-31: $0.001991-12-31: $0.001992-12-31: $0.001993-12-31: $0.001994-12-31: $0.001995-12-31: $0.001996-12-31: $0.001997-12-31: $0.001998-12-31: $0.001999-12-31: $0.002000-12-31: $28.33M2001-12-31: $39.50M2002-12-31: $11.89M2003-12-31: $7.75M2004-12-31: $47.74M2005-12-31: $31.45M2006-12-31: $33.89M2007-12-31: $25.53M2008-12-31: $37.68M2009-12-31: $74.96M2010-12-31: $74.62M2011-12-31: $45.04M2012-12-31: $27.57M2013-12-31: $21.51M2014-12-31: $17.47M2015-12-31: $16.30M2016-12-31: $79.42M2017-12-31: $237.57M2018-12-31: $24.87M2019-12-31: $62.33M2020-12-31: $191.50M2021-12-31: $171.70M2022-12-31: $159.60M2023-12-31: $170.30M2024-12-31: $206.80M2025-12-31: $171.80M$237.57M$0.00
1990-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

VRTX deferred revenue history

Revenue received but not yet earned. The available annual fiscal periods series contains 36 observations from Dec 31, 1990 to Dec 31, 2025.

Vertex Pharmaceuticals Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
171,800,000
206,800,000
170,300,000
159,600,000
171,700,000
191,500,000
62,332,000
24,870,000
237,570,000
79,421,000
16,296,000
17,468,000
21,510,000
27,566,000
45,037,000
74,619,000
74,956,000
37,678,000
25,528,000
33,889,000
31,449,000
47,741,000
7,746,000
11,888,000
39,498,000
28,329,000
0
0
0
0
0
0
0
0
0
0

Compare deferred revenue

All VRTX financial metrics · VRTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.